Cargando…
The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation
As digital health technologies (DHT) have been embraced as a ‘panacea’ for health care systems, they have evolved from a buzzword into a high priority objective for health policy across the globe. In the realm of quality and safety standards for medical devices, the US Food and Drug Administration (...
Autores principales: | Lievevrouw, Elisa, Marelli, Luca, Van Hoyweghen, Ine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Palgrave Macmillan UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116827/ https://www.ncbi.nlm.nih.gov/pubmed/34002115 http://dx.doi.org/10.1057/s41292-021-00232-w |
Ejemplares similares
-
The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
por: Xu, Joshua, et al.
Publicado: (2016) -
OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data
por: Kass-Hout, Taha A, et al.
Publicado: (2016) -
The effects of lobbying on the FDA’s recall classification
por: Zhou, Yifan
Publicado: (2023) -
FDA’s tracking and analysis of surveillance sampling isolates
for outbreak detection
por: Blessington, Tyann, et al.
Publicado: (2017) -
Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022)